Albemarle (ALB-PA) Research & Development (2009 - 2025)

Albemarle has reported Research & Development for 17 years, with the latest figure at $12.4 million in Q2 2025.

• For the quarter ending Q2 2025, Research & Development fell 40.09% year-over-year to $12.4 million; the trailing twelve-month figure through Jun 2025 stood at $69.0 million (down 21.76% YoY), and the FY2025 full-year result was $51.4 million, down 40.73% from the prior year.
• Research & Development for Q2 2025 stood at $12.4 million, down from $14.1 million in the prior quarter.
• The five-year high for Research & Development was $23.5 million in Q1 2024, with the low at $12.1 million in Q4 2021.
• Historically, Research & Development has averaged $18.1 million across 5 years, with a median of $19.2 million in 2022.
• Annual changes were most pronounced in 2022 — Research & Development soared 66.22% — and 2025, when it slumped 40.09%.
• Albemarle's Research & Development stood at $12.1 million in 2021, then jumped by 66.22% to $20.2 million in 2022, then climbed by 12.9% to $22.8 million in 2023, then dropped by 12.01% to $20.0 million in 2024, then tumbled by 37.85% to $12.4 million in 2025.
• The last three Research & Development figures came in at $12.4 million (Q2 2025), $14.1 million (Q1 2025), and $20.0 million (Q4 2024), per Business Quant data.